Thursday , August 22 2019
  • Loading stock data...

Home / Business / What to expect from marijuana stocks after the first big medical cannabis win

What to expect from marijuana stocks after the first big medical cannabis win

By Nigam Arora

Fortunes may be made in legal cannabis over the coming years. As a result, bullish sentiment is building on cannabis stocks both for recreational and medicinal uses.

Adding to the bullish sentiment is the first-ever cannabis-based medicine to get a favorable recommendation from an advisory panel to the U.S. Food and Drug Administration. This is a big win for cannabis.

The drug, a syrup called Epidiolex, is from GW Pharmaceuticals GWPH, +1.97% GW2A, +0.00% to treat childhood epilepsy. The medicine doesn’t have any psychoactive effects.

Read more at MarketWatch

About admin

Check Also

Cannabis Consumers Want Hollywood To Abandon Marijuana Stereotypes

By Mike Adams If Hollywood plans to capitalize on the average cannabis consumer, a new …

Leave a Reply

Your email address will not be published. Required fields are marked *

CONTACT US
Thank You. We will contact you as soon as possible.
SUBSCRIBE TO OUR NEWSLETTER
* we never share your e-mail with third parties.